Government of Saskatchewan ministries, Crown corporations and organizations are working to minimize the impacts of the postal service disruption.
Les ministères, les sociétés d’État et les organismes du gouvernement de la Saskatchewan travaillent à réduire au minimum les répercussions de l’interruption des services postaux.
Google Translate Disclaimer
A number of pages on the Government of Saskatchewan's website have been professionally translated in French. These translations are identified by a yellow box in the right or left rail that resembles the link below. The home page for French-language content on this site can be found at:
Where an official translation is not available, Google™ Translate can be used. Google™ Translate is a free online language translation service that can translate text and web pages into different languages. Translations are made available to increase access to Government of Saskatchewan content for populations whose first language is not English.
Software-based translations do not approach the fluency of a native speaker or possess the skill of a professional translator. The translation should not be considered exact, and may include incorrect or offensive language. The Government of Saskatchewan does not warrant the accuracy, reliability or timeliness of any information translated by this system. Some files or items cannot be translated, including graphs, photos and other file formats such as portable document formats (PDFs).
Any person or entities that rely on information obtained from the system does so at his or her own risk. Government of Saskatchewan is not responsible for any damage or issues that may possibly result from using translated website content. If you have any questions about Google™ Translate, please visit: Google™ Translate FAQs.
Released on September 9, 2013
Saskatchewan to Explore Other Options
The Saskatchewan government has been informed that the Albany Medical Center has decided to stop its clinical trial into the effectiveness of angioplasty in treating chronic cerebro-spinal venous insufficiency (CCSVI) and relieving the symptoms of multiple sclerosis (MS).
Clinical trial lead Dr. Gary Siskin has advised the Ministry of Health that he was unable to meet the target enrolment necessary for the study to produce statistically valid results. Despite Saskatchewan’s 86 planned participants, the research team could not recruit enough total participants to meet United States government requirements for a clinical trial.
“This news is disappointing for the approximately 3,500 Saskatchewan people who want to know whether this kind of treatment can help relieve MS symptoms,” Health Minister Dustin Duncan said. “Our government wants to do everything it can to search for answers and further the science for people with MS. That’s why Saskatchewan was supportive of this trial and will continue to be supportive of research that may provide answers for those with MS and their families.”
Saskatchewan has more people per capita who suffer from MS than anywhere other province in Canada. The Ministry of Health will work with its health and research partners to explore other options.
“We regret that our inability to meet our target enrolment will make it impossible to draw statistically meaningful conclusions from this study,” Dr. Siskin said. “The Government of Saskatchewan should be admired for its forward thinking approach and genuine compassion. The multiple sclerosis community is fortunate to have such a partner in its corner.”
The provincial government had committed up to $2.2 million to have Saskatchewan patients participate in the Albany study. Costs to date have been about $150,000.
MS is a neurological disease of unknown origin that impairs or destroys the functioning of nerve cells in the brain and spinal cord.
-30-
For more information, contact:
Tyler McMurchy
Health
Regina
Phone: 306-787-4083
Email: tmcmurchy@health.gov.sk.ca
Cell: 306-537-3594
We need your feedback to improve saskatchewan.ca. Help us improve
